Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Formerly: Chairman, CEO and President, Synergen Corp. - Aggregate Compensation from the Funds: None - Total Compensation from Fund Complex: $376,150 |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. Member of the Audit Committee; Chair of the Compliance Committee; Member of the Investments Committee |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) The Board believes that Dr. Soll's experience as a chairman of a public company benefits the Funds. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Formerly: Chairman, CEO and President, Synergen Corp. - Compensation: $376,150 - Number of Funds Overseen: 140 |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired; Chair of the Compliance Committee; Member of the Audit Committee and Investments Committee. |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. |
| Filing Date | Source Excerpt |
|---|---|
| 2012-07-03 | Dr. Larry Soll. Formerly, Dr. Soll was chairman of the board (1987 to 1994), chief executive officer (1982 to 1989; 1993 to 1994), and president (1982 to 1989) of Synergen Corp., a biotechnology company, in Boulder, Colorado. He was also a faculty member at the University of Colorado (1974-1980). The Board believes that Dr. Soll's experience as a chairman of a public company and in academia benefits the Target Funds. |
| 2014-07-18 | Larry Soll (1942) - Nominee - Retired - Formerly: Chairman, CEO and President, Synergen Corp. - Aggregate Compensation from Fund Complex: $376,150 |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired Member of the Audit Committee and Compliance Committee |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Member of the Houston Board; Member of the Houston Compliance Committee - Aggregate Compensation from the Funds: None |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) Committees: Compliance Committee, Governance Committee, Investments Committee. Compensation received by the Trustees of the Funds as of fiscal year ended February 28, 2015 is shown on Annex B. |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. The Board believes that Dr. Soll's experience as a chairman of a public company benefits the Funds. |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-02-26 | Larry Soll (67) Proposed Trustee Retired. |
| 2010-06-21 | Larry Soll (68) Trustee Since 2010 Retired.Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). |
| 2011-06-06 | Larry Soll - 1942 Trustee/Director 2010 Retired. Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). |
| 2013-06-17 | Larry Soll - 1942 Trustee 2010 Retired. Compensation: $377,900. |
| 2014-06-27 | Larry Soll - 1942 Trustee 2010 Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. Audit Committee Member |
| 2015-07-09 | Dr. Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) Dr. Soll currently serves as a trustee and a member of the Audit Committee of each of the funds within the Invesco Funds. The Compliance Committee members include Messrs. Bunch, Dammeyer (Vice-Chair), Stickel and Dr. Soll. The Governance Committee members include Messrs. Arch, Crockett, Albert R. Dowden (Chair), Jack M. Fields (Vice-Chair), Hugo F. Sonnenschein, Dr. Prema Mathai-Davis and Ms. Woolsey. The Investments Committee members include Messrs. Arch, Bunch (Chair), Crockett, Dammeyer (Vice-Chair), Dowden, Fields (Vice-Chair), Martin L. Flanagan, Sonnenschein (Vice-Chair), Stickel, Philip A. Taylor, Ms. Woolsey and Drs. Mathai-Davis and Soll. |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired; Former Chairman, CEO and President, Synergen Corp.; Chair of the Compliance Committee. |
| 2017-07-26 | Dr. Larry Soll has been a member of the Board of Trustees of the Invesco Funds since 1997. |
| Filing Date | Source Excerpt |
|---|---|
| 2012-07-03 | Larry Soll. Formerly, Dr. Soll was chairman of the board (1987 to 1994), chief executive officer (1982 to 1989; 1993 to 1994), and president (1982 to 1989) of Synergen Corp., a biotechnology company, in Boulder, Colorado. He was also a faculty member at the University of Colorado (1974-1980). The Board believes that Dr. Soll's experience as a chairman of a public company and in academia benefits PIA. |
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Formerly: Chairman, CEO and President, Synergen Corp. - Aggregate Compensation from Fund Complex: $376,150 |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. |
| 2017-07-26 | Dr. Larry Soll has been a member of the Board of Trustees of the Invesco Funds since 1997. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Formerly: Chairman, CEO and President, Synergen Corp. - Aggregate Compensation from Fund Complex: $376,150 |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. |
| 2017-07-26 | Larry Soll - 1942, Trustee, Retired; Former Chairman, CEO and President, Synergen Corp.; Member of the Audit Committee and Compliance Committee. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Larry Soll (1942) Nominee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) The Board believes that Dr. Soll's experience as a chairman of a public company and in academia benefits the Funds. |
| 2016-07-20 | Larry Soll - 1942 Trustee Former Chairman, CEO and President of Synergen Corp.; Chair of Audit Committee; Chair of Compliance Committee; Member of Investments Committee. |
| 2017-07-26 | Dr. Larry Soll has been a member of the Board of Trustees of the Invesco Funds since 1997. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-02-26 | Larry Soll (67) Proposed Trustee Retired. |
| 2010-06-21 | Larry Soll (68) Trustee Since 2010 Retired.Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). |
| 2011-06-06 | Larry Soll - 1942 Trustee/Director 2010 Retired.Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). |
| 2012-07-03 | Larry Soll - 1942 Trustee 2010 Retired. Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). The Board believes that Dr. Soll's experience as a chairman of a public company and in academia benefits the Funds. |
| 2013-06-17 | Larry Soll - 1942 Trustee 2010 Retired. Compensation: $377,900. Committees: Audit Committee, Compliance Committee, Investments Committee. |
| 2014-06-27 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2016-07-20 | Dr. Larry Soll has been a member of the Board of Trustees of the Invesco Funds since 1997. Formerly, Dr. Soll was Chairman of the Board (1987 to 1994), Chief Executive Officer (1982 to 1989; 1993 to 1994) and President (1982 to 1989) of Synergen Corp., a public company. The Board believes that Dr. Soll's experience as a chairman of a public company benefits the Funds. |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. The Board believes that Dr. Soll's experience as a chairman of a public company benefits the Funds. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Member of the Houston Board - Aggregate Compensation from Fund Complex: $376,150 |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) The Board believes that Dr. Soll's experience as a chairman of a public company and in academia benefits the Funds. Committees: Audit Committee, Compliance Committee, Governance Committee, Investments Committee. Compensation: $372,900. |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Dr. Larry Soll (1942) - Nominee - Retired - Formerly: Chairman, CEO and President, Synergen Corp. - Aggregate Compensation from Fund Complex: $376,150 |
| 2015-07-09 | Larry Soll - 1942, Trustee; Retired; Formerly Chairman, CEO and President, Synergen Corp.; Trustee and member of the Audit Committee of each of the funds within the Invesco Funds. |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Former Chairman, CEO and President of Synergen Corp. Chair of the Audit Committee. Member of the Compliance Committee and Investments Committee. |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| Filing Date | Source Excerpt |
|---|---|
| 2012-07-03 | Larry Soll. Formerly, Dr. Soll was chairman of the board (1987 to 1994), chief executive officer (1982 to 1989; 1993 to 1994), and president (1982 to 1989) of Synergen Corp., a biotechnology company, in Boulder, Colorado. ... The Target Fund Board believes that Dr. Soll's experience as a chairman of a public company and in academia benefits the Target Fund. |
| 2014-07-18 | Larry Soll (1942) Nominee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) Houston Compliance Committee |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) Compensation received by the Trustees of the Funds as of fiscal year ended February 28, 2015 is shown on Annex B. |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired; Chair of the Compliance Committee; Member of the Audit Committee and Investments Committee. |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-02-26 | Larry Soll (67) Proposed Trustee Retired. Trustee of 149 funds/portfolios in the AIM Family of Funds. |
| 2010-06-21 | Larry Soll (68) Trustee Since 2010 Retired. Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). |
| 2011-06-06 | Dr. Larry Soll, Trustee/Director. Dr. Larry Soll has been a member of the Board since 1997. Formerly, Dr. Soll was chairman of the board (1987 to 1994), chief executive officer (1982 to 1989; 1993 to 1994), and president (1982 to 1989) of Synergen Corp. |
| 2012-07-03 | Larry Soll - 1942 Trustee 2010 Retired. Formerly, Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company). The Board of each Fund believes that Dr. Soll's experience as a chairman of a public company and in academia benefits the Funds. |
| 2013-06-17 | Larry Soll - 1942 Trustee 2010 Retired. Committees: Audit Committee, Compliance Committee, Investments Committee. Compensation: $377,900. |
| 2014-06-27 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) |
| 2015-07-09 | Larry Soll - 1942 Trustee Retired Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) 144 None |
| 2016-07-20 | Dr. Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. Trustee and a member of the Audit Committee of each of the funds within the Invesco Funds |
| 2017-07-26 | Larry Soll - 1942 Trustee Retired. Formerly: Chairman, Chief Executive Officer and President, Synergen Corp. (a biotechnology company) The Board believes that Dr. Soll's experience as a chairman of a public company benefits the Funds. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22